# Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD

> **NCT04052698** · PHASE3 · COMPLETED · sponsor: **Octapharma** · enrollment: 43 (actual)

## Conditions studied

- Von Willebrand Diseases

## Interventions

- **DRUG:** Wilate

## Key facts

- **NCT ID:** NCT04052698
- **Lead sponsor:** Octapharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-18
- **Primary completion:** 2022-04-23
- **Final completion:** 2022-04-23
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2023-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04052698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04052698, "Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04052698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*